Carterra CEO, Josh Eckman, Recognized as a Rising Star by the David Eccles School of Business
June 7, 2018
Carterra® Inc., a provider of innovative drug discovery technologies, announced that its CEO, Josh Eckman, has been honored as a Rising Star by The University of Utah David Eccles School of Business during its 2018 Hall of Fame induction ceremony.
LakePharma Expands Service Capability with Purchase of Carterra™ High Throughput Antibody Characterization LSA™ Instrumentation
April 26, 2018
First Contract Development & Manufacturing Organization to Install Carterra’s Next Generation Label-Free Biosensor to Support Antibody Discovery Services Business
Institute for Protein Innovation Buys Carterra™ Next-Generation Antibody Characterization LSA™ Instrumentation
April 4, 2018
First Research Institution to Purchase Carterra’s High-Throughput Label-Free Biosensor to Support its Novel Antibody Discovery
Carterra™ Announces Multiple Sales of its New LSA™ Array SPR Instrument for Comprehensive Monoclonal Antibody Characterization
March 13, 2018
First LSA instrument sales are to a broad range of initial customers, including large pharmaceutical, biotech, CRO and academic institutions.
Carterra Inc. Raises $10M from Telegraph Hill Partners to Develop and Launch Next-Generation Antibody Characterization Platform
January 17, 2018
Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization.
Wasatch Microfluidics Announces Name Change to Carterra Inc. and New High Throughput SPRi Instrument
May 1, 2017
New corporate name and system reflect the evolution of the Company into a premier provider of biotherapeutic characterization tools.